Pietro graduated in Pharmacy from the University of Perugia and the School of Pharmacy in London. He began his career at Advanced Accelerator Applications, a radiopharmaceutical leader acquired by Novartis in 2018, managing various production sites in Italy and America. He currently serves as VP Manufacturing & Operations at BetaGlue Therapeutics.
Return
Pietro Bubba Bello